当前位置:首页 - 行情中心 - 安图生物(603658) - 财务分析 - 现金流量表

安图生物

(603658)

  

流通市值:231.48亿  总市值:231.48亿
流通股本:5.71亿   总股本:5.71亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,198,247,562.321,121,264,719.64,876,632,472.13,588,333,799.99
  收到的税费返还8,453,225.55-35,526,258.9414,455,113.45
  收到其他与经营活动有关的现金113,353,151.9689,678,591.42181,636,034.28152,019,925.53
  经营活动现金流入小计2,320,053,939.831,210,943,311.025,093,794,765.323,754,808,838.97
  购买商品、接受劳务支付的现金727,322,634.79373,420,356.811,642,915,029.711,119,437,175.34
  支付给职工以及为职工支付的现金673,170,786.68476,776,379.071,168,421,510.44911,919,041.54
  支付的各项税费262,991,988.1772,647,267.29429,424,829.3361,803,976.3
  支付其他与经营活动有关的现金246,384,604.84121,760,849.59543,750,654.75412,683,231.13
  经营活动现金流出小计1,909,870,014.481,044,604,852.763,784,512,024.22,805,843,424.31
  经营活动产生的现金流量净额410,183,925.35166,338,458.261,309,282,741.12948,965,414.66
二、投资活动产生的现金流量:
  取得投资收益收到的现金894,348---
  处置固定资产、无形资产和其他长期资产收回的现金净额10,082.36,000206,937.34186,437.34
  收到的其他与投资活动有关的现金2,767,068,985.8410,018,513.892,622,846,961.491,427,401,160.48
  投资活动现金流入小计2,767,973,416.1410,024,513.892,623,053,898.831,427,587,597.82
  购建固定资产、无形资产和其他长期资产支付的现金326,499,808.64146,794,114.2664,401,544.3540,936,540.08
  投资支付的现金7,500,0007,500,00055,500,00025,500,000
  取得子公司及其他营业单位支付的现金--1,761,567.471,761,567.47
  支付其他与投资活动有关的现金2,131,839,077.53236,722,718.033,086,618,209.921,832,453,251.15
  投资活动现金流出小计2,465,838,886.17391,016,832.233,808,281,321.692,400,651,358.7
  投资活动产生的现金流量净额302,134,529.97-380,992,318.34-1,185,227,422.86-973,063,760.88
三、筹资活动产生的现金流量:
  吸收投资收到的现金14,455,00014,455,000--
  其中:子公司吸收少数股东投资收到的现金14,455,00014,455,000--
  取得借款收到的现金361,670,786.89291,970,786.89503,000,000503,000,000
  收到其他与筹资活动有关的现金919,397,210.85439,770,402.48783,955,484.92559,161,991.98
  筹资活动现金流入小计1,295,522,997.74746,196,189.371,286,955,484.921,062,161,991.98
  偿还债务支付的现金779,970,786.89488,000,000654,000,000648,000,000
  分配股利、利润或偿付利息支付的现金727,179,676.693,463,420.84627,310,854.28624,190,333.71
  其中:子公司支付给少数股东的股利、利润2,102,100-3,930,6003,930,600
  支付其他与筹资活动有关的现金501,655,814.9275,840,504.051,164,474,576.14932,031,817.73
  筹资活动现金流出小计2,008,806,278.48767,303,924.892,445,785,430.422,204,222,151.44
  筹资活动产生的现金流量净额-713,283,280.74-21,107,735.52-1,158,829,945.5-1,142,060,159.46
四、汇率变动对现金及现金等价物的影响3,246,257.443,228,949.871,463,670.6541,957.13
五、现金及现金等价物净增加额2,281,432.02-232,532,645.73-1,033,310,956.64-1,165,616,548.55
  加:期初现金及现金等价物余额452,058,348.81452,058,348.811,485,369,305.451,485,369,305.45
  期末现金及现金等价物余额454,339,780.83219,525,703.08452,058,348.81319,752,756.9
补充资料:
  净利润578,036,989.75-1,199,233,279.89-
  资产减值准备14,215,837.01-62,954,217.56-
  固定资产和投资性房地产折旧215,464,941.83-433,709,122.57-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧215,464,941.83-433,709,122.57-
  无形资产摊销13,748,734.82-30,492,330.54-
  长期待摊费用摊销12,897,921.42-31,454,036.31-
  处置固定资产、无形资产和其他长期资产的损失-38,609.84-1,169,696.21-
  固定资产报废损失1,562,991.87-11,355,581.92-
  公允价值变动损失54,112.42--3,609,780.75-
  财务费用9,517,542.81-21,653,584.35-
  投资损失-67,250,439.05--92,272,195.9-
  递延所得税-529,134.49--34,884,593.88-
  其中:递延所得税资产减少-20,410,900.74--61,041,511.47-
    递延所得税负债增加19,881,766.25-26,156,917.59-
  存货的减少57,006,242.84--365,941,785.02-
  经营性应收项目的减少-215,522,717.17--62,360,213-
  经营性应付项目的增加-204,841,745.56--36,953,893.1-
  其他-7,539,635.35-44,094,456.33-
  现金的期末余额454,339,780.83-452,058,348.81-
  减:现金的期初余额452,058,348.81-1,485,369,305.45-
  现金及现金等价物的净增加额2,281,432.02--1,033,310,956.64-
公告日期2025-08-222025-04-182025-04-182024-10-26
审计意见(境内)标准无保留意见
TOP↑